There is a role for hormone treatment, either with aromatase inhibitors, progesterone, or gonadotropin releasing hormone (GnRH) agonists, for the treatment of metastatic disease, tumor recurrence, or unresectable tumors. Here, GNRH1 is linked to neoplasm.